Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases

Qing Ye1, Xiao-Jun Xu2, Wen-Xia Shao3

  • 1Clinical Laboratory, The Children's Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.

Insights

Mycoplasma pneumoniae infection in children is linked to higher immunoglobulin E (IgE) levels and allergic diseases. This study reveals a Th1/Th2 cytokine imbalance contributing to these allergic responses.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Allergy and Asthma Research

Background:

  • Mycoplasma pneumoniae (MP) is a leading cause of childhood pneumonia.
  • Understanding the link between MP infection and secondary allergic conditions is crucial for effective management.

Purpose of the Study:

  • To investigate the relationship between Mycoplasma pneumoniae infection and secondary allergic diseases.
  • To elucidate the immunological mechanisms, including cytokine profiles and T-cell responses, underlying this association.

Main Methods:

  • A prospective study involving 1330 children diagnosed with pneumonia.
  • Analysis of serum immunoglobulin E (IgE) levels, cytokines (IL-4, IL-5, IL-6, IL-10, INF-γ), and T-cell subsets (CD4+, CD8+) secreting IL-4.
  • Correlation of immune markers with clinical severity and allergic outcomes, including asthma development.

Main Results:

  • Children with Mycoplasma pneumoniae pneumonia (MPP) showed elevated serum IgE, IL-4, IL-6, and IL-10 during the acute phase compared to recovery.
  • MPP patients with allergies exhibited higher IgE and an increased IL-4/INF-γ ratio.
  • Elevated IgE and Eosinophil Cationic Protein were observed in patients who developed secondary asthma; severe cases showed higher IL-4 and IL-5.

Conclusions:

  • Mycoplasma pneumoniae infection is significantly correlated with elevated IgE levels in children.
  • A Th1/Th2 cytokine imbalance and increased IL-4 production by T cells are associated with MP infection and allergic responses.
  • These findings highlight MP's role in triggering or exacerbating allergic conditions, including asthma.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
80
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
88
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
32
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K